Maria Carolina de Oliveira Rodrigues in research grants and scholarships supported by FAPESP.
| Articles published in Pesquisa para Inovação FAPESP about the researcher: |
| Artificial skin can assist development of treatments for systemic sclerosis |
| More itemsLess items |
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
We propose a program of basic and clinical research to isolate, culture, and characterize embryonic ,somatic, and neoplastic stem cells in order to understand their biology and apply this knowledge to therapy, comprising four research lines: (1) pluripotent stem cells (SC) (embryonic SC and induced pluripotent SC); (2) somatic SC (hematopoietic SC, mesenchymal SC, endothelial SC, and canc…
Systemic sclerosis (SSc) is an autoimmune disease marked by fibrosis of the skin and internal organs, immune dysregulation and vasculopathy. Autologous hematopoietic stem cell transplantation (AHSCT) has been investigated as treatment for patients with severe and progressive SSc. Although patients show great clinical and histopathological improvement of cutaneous fibrosis after transplant…
Systemic sclerosis is an autoimmune disease characterized by microvasculopathy, immune dysregulation and excessive production of collagen, resulting fibrosis of the skin and internal organs. The etiology of SSc remains unknown, and treatment is organ-directed, based on the extent and severity of lesions. The efficacy of conventional therapeutic strategies for SSc is limited, especially in…
Systemic Sclerosis (SSc) is a rheumatic disease that causes progressive fibrosis of the skin and may affect internal organs. It presents high morbidity and mortality, and in severe cases, where cutaneous involvement is diffuse or in which there is involvement of the lungs, heart or kidneys, mortality may reach 30 to 50% in five years, even under conventional immunosuppressive treatment. A…
Systemic sclerosis (SSc) is a rheumatic disease that causes progressive fibrosis of the skin and may affect internal organs. It presents high morbidity and mortality, and in severe cases, where cutaneous involvement is diffuse or in which there is involvement of the lungs, heart or kidneys, mortality may reach 30 to 50% in five years, even under conventional immunosuppressive treatment. A…
(Only some records are available in English at this moment)
Systemic sclerosis (SSc) is an autoimmune disease marked by fibrosis of the skin and internal organs, immune dysregulation, and vasculopathy. The skin fibrosis in SSc results from the activation of the resident fibroblasts by immune cells. SSc fibroblasts synthesize, in an aberrant manner, many extracellular matrix molecules (ECM), contributing to skin thickening and stiffening. Thus, we …
The present study will be conducted in the University of South Florida Department of Neurosurgery. This is an important center of research for amyotrophic lateral sclerosis (ALS), under the leadership of Dr. Garbuzova-Davis. In this center are developed experimental studies with the ALS mouse transgenic model (G93A-SOD1 mutation), besides studies with human tissue from ALS patients. The p…
| 1 / 1 | Ongoing research grants |
| 1 / 0 | Completed research grants |
| 1 / 1 | Ongoing scholarships in Brazil |
| 4 / 4 | Completed scholarships in Brazil |
| 2 / 2 | Completed scholarships abroad |
| 9 / 8 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID